Secretory granule exocytosis and its amplification by cAMP in pancreatic β-cells
Nagao, Mototsugu LU ; Lagerstedt, Jens O. LU and Eliasson, Lena LU
(2022)
In Diabetology International
13(3).
p.471-479
- Abstract
The sequence of events for secreting insulin in response to glucose in pancreatic β-cells is termed “stimulus-secretion coupling”. The core of stimulus-secretion coupling is a process which generates electrical activity in response to glucose uptake and causes Ca2+ oscillation for triggering exocytosis of insulin-containing secretory granules. Prior to exocytosis, the secretory granules are mobilized and docked to the plasma membrane and primed for fusion with the plasma membrane. Together with the final fusion with the plasma membrane, these steps are named the exocytosis process of insulin secretion. The steps involved in the exocytosis process are crucial for insulin release from β-cells and considered indispensable for... (More)
The sequence of events for secreting insulin in response to glucose in pancreatic β-cells is termed “stimulus-secretion coupling”. The core of stimulus-secretion coupling is a process which generates electrical activity in response to glucose uptake and causes Ca2+ oscillation for triggering exocytosis of insulin-containing secretory granules. Prior to exocytosis, the secretory granules are mobilized and docked to the plasma membrane and primed for fusion with the plasma membrane. Together with the final fusion with the plasma membrane, these steps are named the exocytosis process of insulin secretion. The steps involved in the exocytosis process are crucial for insulin release from β-cells and considered indispensable for glucose homeostasis. We recently confirmed a signature of defective exocytosis process in human islets and β-cells of obese donors with type 2 diabetes (T2D). Furthermore, cyclic AMP (cAMP) potentiates glucose-stimulated insulin secretion through mechanisms including accelerating the exocytosis process. In this mini-review, we aimed to organize essential knowledge of the secretory granule exocytosis and its amplification by cAMP. Then, we suggest the fatty acid translocase CD36 as a predisposition in β-cells for causing defective exocytosis, which is considered a pathogenesis of T2D in relation to obesity. Finally, we propose potential therapeutics of the defective exocytosis based on a CD36-neutralizing antibody and on Apolipoprotein A-I (ApoA-I), for improving β-cell function in T2D.
(Less)
- author
- Nagao, Mototsugu
LU
; Lagerstedt, Jens O.
LU
and Eliasson, Lena
LU
- organization
- publishing date
- 2022
- type
- Contribution to journal
- publication status
- published
- subject
- keywords
- Apolipoprotein A-I, CD36, Diabetes, Exocytosis, Insulin secretion, Type 2 diabetes, β-Cell
- in
- Diabetology International
- volume
- 13
- issue
- 3
- pages
- 471 - 479
- publisher
- Springer
- external identifiers
-
- pmid:35694000
- scopus:85127536763
- ISSN
- 2190-1678
- DOI
- 10.1007/s13340-022-00580-3
- language
- English
- LU publication?
- yes
- id
- 8987ce44-ccc9-45d3-a61b-ca9ba1250aaa
- date added to LUP
- 2022-05-04 15:24:48
- date last changed
- 2024-04-18 09:14:49
@article{8987ce44-ccc9-45d3-a61b-ca9ba1250aaa,
abstract = {{<p>The sequence of events for secreting insulin in response to glucose in pancreatic β-cells is termed “stimulus-secretion coupling”. The core of stimulus-secretion coupling is a process which generates electrical activity in response to glucose uptake and causes Ca<sup>2+</sup> oscillation for triggering exocytosis of insulin-containing secretory granules. Prior to exocytosis, the secretory granules are mobilized and docked to the plasma membrane and primed for fusion with the plasma membrane. Together with the final fusion with the plasma membrane, these steps are named the exocytosis process of insulin secretion. The steps involved in the exocytosis process are crucial for insulin release from β-cells and considered indispensable for glucose homeostasis. We recently confirmed a signature of defective exocytosis process in human islets and β-cells of obese donors with type 2 diabetes (T2D). Furthermore, cyclic AMP (cAMP) potentiates glucose-stimulated insulin secretion through mechanisms including accelerating the exocytosis process. In this mini-review, we aimed to organize essential knowledge of the secretory granule exocytosis and its amplification by cAMP. Then, we suggest the fatty acid translocase CD36 as a predisposition in β-cells for causing defective exocytosis, which is considered a pathogenesis of T2D in relation to obesity. Finally, we propose potential therapeutics of the defective exocytosis based on a CD36-neutralizing antibody and on Apolipoprotein A-I (ApoA-I), for improving β-cell function in T2D.</p>}},
author = {{Nagao, Mototsugu and Lagerstedt, Jens O. and Eliasson, Lena}},
issn = {{2190-1678}},
keywords = {{Apolipoprotein A-I; CD36; Diabetes; Exocytosis; Insulin secretion; Type 2 diabetes; β-Cell}},
language = {{eng}},
number = {{3}},
pages = {{471--479}},
publisher = {{Springer}},
series = {{Diabetology International}},
title = {{Secretory granule exocytosis and its amplification by cAMP in pancreatic β-cells}},
url = {{http://dx.doi.org/10.1007/s13340-022-00580-3}},
doi = {{10.1007/s13340-022-00580-3}},
volume = {{13}},
year = {{2022}},
}